Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Alcon Laboratories (UK) Ltd Pentagon Park Boundary Way HemelHempstead Herts. HP2 7UD
Betoptic is indicated for the reduction of elevated intraocular pressure in patients with ocular hypertension and chronic open angle glaucoma.
Adults (including the elderly): The usual dose is one drop to be instilled into the affected eye(s) twice daily.
Children: Betoptic is not recommended for use in children.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity.
A topical overdose of Betoptic may be flushed from the eye(s) with warm tap water.
Unopened 36 months, after opening 28 days.
Do not store above 25°C.
Keep in the outer carton in order to protect from light.
5 ml & 10 ml LDPE bottles (10 ml present in 15 ml container) with natural LDPE plug and blue polystyrene or polypropylene cap.
Do not touch the top of the bottle to any surface as this may contaminate the contents.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
